Cargando…

Past, Present and Future of Oncolytic Reovirus

SIMPLE SUMMARY: Within this review article the authors provide an unbiased review of the oncolytic virus, reovirus, clinically formulated as pelareorep. In particular, the authors summarise what is known about the molecular and cellular requirements for reovirus oncolysis and provide a comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Louise, Berkeley, Robert, Barr, Tyler, Ilett, Elizabeth, Errington-Mais, Fiona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693452/ https://www.ncbi.nlm.nih.gov/pubmed/33142841 http://dx.doi.org/10.3390/cancers12113219

Ejemplares similares

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
por: Jennings, VA, et al.
Publicado: (2014)

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
por: Parrish, C, et al.
Publicado: (2015)

Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
por: Samson, Adel, et al.
Publicado: (2018)

Oncolytic Virotherapy for Multiple Myeloma: Past, Present, and Future
por: Thirukkumaran, Chandini M., et al.
Publicado: (2011)

Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche
por: Müller, Louise M E, et al.
Publicado: (2021)

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus
por: Kemp, Vera, et al.
Publicado: (2015)

Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy
por: Kumar, Vishnupriyan, et al.
Publicado: (2021)

Oncolytic Reovirus in Canine Mast Cell Tumor
por: Hwang, Chung Chew, et al.
Publicado: (2013)

Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery
por: Kemp, Vera, et al.
Publicado: (2017)

Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
por: Chianese, Annalisa, et al.
Publicado: (2021)

Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming
por: Steele, Lynette, et al.
Publicado: (2011)

The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
por: Alain, T, et al.
Publicado: (2006)

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway
por: Twigger, Katie, et al.
Publicado: (2012)

Oncolytic Seneca Valley Virus: past perspectives and future directions
por: Burke, Michael J
Publicado: (2016)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

The oncolytic effects of reovirus in canine solid tumor cell lines
por: IGASE, Masaya, et al.
Publicado: (2015)

Reovirus-Mediated Cytotoxicity and Enhancement of Innate Immune Responses Against Acute Myeloid Leukemia
por: Hall, Kathryn, et al.
Publicado: (2012)

Heparin: Past, Present, and Future
por: Oduah, Eziafa I., et al.
Publicado: (2016)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2017)

Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells
por: Inagaki, Yusuke, et al.
Publicado: (2017)

Hypertrophic Cardiomyopathy—Past, Present and Future
por: Liew, Alphonsus C., et al.
Publicado: (2017)

PCR past, present and future
por: Zhu, Hanliang, et al.
Publicado: (2020)

Loricrin: Past, Present, and Future
por: Ishitsuka, Yosuke, et al.
Publicado: (2020)

Frailty: Past, present, and future?
por: Kwak, Dongmin, et al.
Publicado: (2020)

Sharka: The Past, The Present and The Future
por: Sochor, Jiri, et al.
Publicado: (2012)

Trachoma: Past, present and future
por: Mohammadpour, Mehrdad, et al.
Publicado: (2016)

Astaxanthin: Past, Present, and Future
por: Nishida, Yasuhiro, et al.
Publicado: (2023)

Kinetics of Oncolytic Reovirus T3D Replication and Growth Pattern in Mesenchymal Stem Cells
por: Banijamali, Razieh Sadat, et al.
Publicado: (2020)

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
por: Harrington, K.J., et al.
Publicado: (2010)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
por: Kelly, Kevin R., et al.
Publicado: (2017)

Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer
por: Mostafa, Ahmed A., et al.
Publicado: (2018)

Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2018)

Oncolytic Viruses: Do They Have a Role in Anti-Cancer Therapy?
por: Prestwich, Robin J, et al.
Publicado: (2008)

Global epidemiology of canine rabies: past, present, and future prospects
por: Taylor, Louise H, et al.
Publicado: (2015)

Ferroptosis: past, present and future
por: Li, Jie, et al.
Publicado: (2020)

PEComas: the past, the present and the future
por: Martignoni, Guido, et al.
Publicado: (2007)

Condoms: Past, present, and future
por: Marfatia, Y. S., et al.
Publicado: (2015)

Teratology – past, present and future
por: Ujházy, Eduard, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qfsc2ds923lgaenkks35c39qlv